دورية أكاديمية

Desonide Nanoemulsion Gel for Transdermal Absorption Drug Delivery: Pharmacodynamic and Safety Evaluation.

التفاصيل البيبلوغرافية
العنوان: Desonide Nanoemulsion Gel for Transdermal Absorption Drug Delivery: Pharmacodynamic and Safety Evaluation.
المؤلفون: Zhang J; Guangdong Provincial Key Laboratory of Advanced Drug Delivery Systems, Guangdong Pharmaceutical University, Guangzhou, 510000, China., Yao Y; Guangdong Provincial Key Laboratory of Advanced Drug Delivery Systems, Guangdong Pharmaceutical University, Guangzhou, 510000, China., Liu H; Guangdong Provincial Key Laboratory of Advanced Drug Delivery Systems, Guangdong Pharmaceutical University, Guangzhou, 510000, China., Ma Q; Guangdong Provincial Key Laboratory of Advanced Drug Delivery Systems, Guangdong Pharmaceutical University, Guangzhou, 510000, China., Huang L; Guangdong Provincial Key Laboratory of Advanced Drug Delivery Systems, Guangdong Pharmaceutical University, Guangzhou, 510000, China., Chen Y; College of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510000, China., Lin H; Guangdong Provincial Key Laboratory of Advanced Drug Delivery Systems, Guangdong Pharmaceutical University, Guangzhou, 510000, China.
المصدر: Current drug delivery [Curr Drug Deliv] 2023; Vol. 20 (10), pp. 1525-1532.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 101208455 Publication Model: Print Cited Medium: Internet ISSN: 1875-5704 (Electronic) Linking ISSN: 15672018 NLM ISO Abbreviation: Curr Drug Deliv Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Saif Zone, Sharjah, U.A.E. ; San Francisco, CA : Bentham Science Publishers, c2004-
مواضيع طبية MeSH: Skin Absorption* , Eczema*/metabolism, Mice ; Animals ; Rabbits ; Skin/metabolism ; Desonide/metabolism ; Desonide/pharmacology ; Administration, Cutaneous ; Emulsions ; Gels/pharmacology
مستخلص: Background: When administered transdermally, desonide is ineffective due to its poor solubility. As a new transdermal delivery system, nanoemulsion gel has demonstrated significant advantages for drug delivery over conventional formulations. We have established desonide nanoemulsion gel (DES NE gel) for better transdermal absorption, but its efficacy and safety still need to be evaluated. This study aims to provide additional evidence demonstrating the improved pharmacodynamics and safety of transdermal delivery of Desonide via nanoemulsion gel.
Methods: Pharmacodynamics and safety of Desonide nanoemulsion gel were evaluated using Desonate ® as the reference formulation. To assess the difference in curative effect between DES NE gel and Desonate ® and to ensure safety, atopic dermatitis (AD) models in KM mice were developed using 2,4-dinitrofluorobenzene (DNFB). The degree of ear swelling, ear mass difference, thymus, spleen index, and HE conventional pathology of mice were used as pharmacodynamic evaluation indexes, and the irritation was predicted by the New Zealand rabbit epidermal stimulation assay.
Results: Nanoemulsion gels may facilitate transdermal penetration of drugs by influencing the skin condition. Medium and high doses of DES NE gel significantly ameliorated the inflammation and swelling of the ear caused by dermatitis/eczema in mice. In addition, compared with DES gel, skin irritation extent did not increase.
Conclusion: Nanoemulsion gel can be applied to improve the efficacy of drugs with low potency or poor solubility. DES NE gel provides a higher transdermal potential than other delivery systems. In this study, it was found that nanoemulsion gel is a promising percutaneous carrier of DES. DES NE-GEL has a significant curative effect on dermatitis/eczema in a mouse model and is expected to provide a new, efficient, and low toxic preparation for clinical treatment of dermatitis/eczema through the percutaneous system.
(Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
فهرسة مساهمة: Keywords: Desonide; eczema; nanoemulsion gel; pharmacodynamic research; potency; safety evaluation
المشرفين على المادة: J280872D1O (Desonide)
0 (Emulsions)
0 (Gels)
تواريخ الأحداث: Date Created: 20220820 Date Completed: 20230522 Latest Revision: 20230522
رمز التحديث: 20230522
DOI: 10.2174/1567201819666220819110128
PMID: 35986531
قاعدة البيانات: MEDLINE
الوصف
تدمد:1875-5704
DOI:10.2174/1567201819666220819110128